0001140361-21-020110.txt : 20210607 0001140361-21-020110.hdr.sgml : 20210607 20210607203017 ACCESSION NUMBER: 0001140361-21-020110 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210603 FILED AS OF DATE: 20210607 DATE AS OF CHANGE: 20210607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meiers James R. CENTRAL INDEX KEY: 0001860603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 211000973 MAIL ADDRESS: STREET 1: C/O TILRAY, INC. STREET 2: 745 FIFTH AVENUE, SUITE 160 CITY: NEW YORK STATE: NY ZIP: 10151 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 824310622 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 745 FIFTH AVENUE STREET 2: SUITE 1602 CITY: NEW YORK STATE: NY ZIP: 10151 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 745 FIFTH AVENUE STREET 2: SUITE 1602 CITY: NEW YORK STATE: NY ZIP: 10151 4 1 form4.xml FORM 4 X0306 4 2021-06-03 0001731348 Tilray, Inc. TLRY 0001860603 Meiers James R. C/O TILRAY, INC. 745 FIFTH AVENUE, SUITE 1602 NEW YORK NY 10151 true Head of Canada Class 2 Common Stock 2021-06-03 4 S 0 23826 19.64 D 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.54 to $19.70, inclusive. The reporting person undertakes to provide to Tilray, Inc., any security holder of Tilray, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). /s/ Carl A. Merton, as Attorney-in-Fact for James R. Meiers 2021-06-07